tag:blogger.com,1999:blog-5574479.post426890558250376304..comments2024-03-29T13:59:42.629+00:00Comments on The IPKat: "Inappropriate and misleading": whatever happened to the original EPO response?Verónica RodrÃguez Arguijohttp://www.blogger.com/profile/05763207846940036921noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-5574479.post-55701900273589768272009-03-23T08:02:00.000+00:002009-03-23T08:02:00.000+00:00I read the EPO comments on Celex before reading th...I read the EPO comments on Celex before reading this note and felt they were responsible and helpful. Surely this is just good editing. As we discovered at the IBIL seminar, we run the risk of being ignored as cranks if responses are heated and emotional. There is a balance to be struck if the European public is to have a vibrant pharma business for the benefit of its economy and drugs that are good value and accessible to those who need them.Filemothttps://www.blogger.com/profile/15735898485265104580noreply@blogger.comtag:blogger.com,1999:blog-5574479.post-5729150688689334912009-03-23T07:28:00.000+00:002009-03-23T07:28:00.000+00:00Jeremy, since these sort of EPO reports are highly...Jeremy, since these sort of EPO reports are highly political you cannot expect that reason and logic are the main driving factors for either the original report or its changes.Anonymousnoreply@blogger.com